- Science
- Global
Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models
- April 6, 2026 at 10:00 PM
- 5 views
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Communications Medicine. The strategy extended survival in preclinical models of glioblastoma, the most aggressive form of brain cancer.
Originally published at Phys.org